Glaxo (GSK), Human Genome Sciences (HGSI) win FDA approval of lupus drug Benlysta
Tweet
Share
E-mailGet Alerts GSK Hot Sheet
Join SI Premium – FREE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shares in this major AI chipmakers are "inexpensive": Barclays
- This name is "a later-cycle beneficiary of the AI spending cycle": Goldman
- Walmart expected to beat Q2 estimates as tariff refunds lift margins
Create E-mail Alert Related Categories
FDA, Hot FDA News, Hot List, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
